Nkgen Biotech Inc (NKGN)

$0.26 +0.07 (35.91%)
Market Cap 8.60M
Revenue (ttm) 0.00
Net Income (ttm) -82.94M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.10
Volume 1,562,500
Avg Vol 4,676,562
Day's Range N/A - N/A
Shares Out 44.95M
Stochastic %K 0%
Beta 0.45
Analysts Strong Buy
Price Target N/A

Company Profile

NKGen Biotech, Inc., a clinical-stage biotechnology company, develops and commercializes cell therapies for neurodegenerative and oncological diseases based on activated natural killer (NK) cells in the United States. The company develops SNK01, an autologous NK cell therapy candidate in Phase I/IIa trial for the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease; and SNK02, which consists of an allogenic NK cell therapy that has completed Phase 1 trial and a HE...

Industry: Biotechnology
Sector: Healthcare
Phone: 949-396-6830
Address:
3001 Daimler Street, Santa Ana, United States
prismmarketview
prismmarketview Nov. 25 at 5:13 PM
PRISM Mid-Day Movers: Global Health and NextGen tech & AI Lead Todays Charge. NKGen Biotech (NASDAQ: $NKGN) jumped about 48% to $0.031, driven by speculative interest and volatility, while Symbotic (NASDAQ: $SYM) surged 34% to $74.52 after beating Q4 revenue estimates with $618.5M and strong growth signals, reflecting bullish momentum. Other Notable Movers: Amentum ( $AMTM) up 20% Roadzen ( $RDZN) up 11% GreenPower Motor Company Inc. ( $GP.X) https://prismmarketview.com/prism-mid-day-movers-global-health-and-nextgen-tech-ai-lead-todays-charge/
0 · Reply
Picklerinthekitchen
Picklerinthekitchen Nov. 25 at 2:32 AM
$NKGN finally .03 !
0 · Reply
Abdullah5566
Abdullah5566 Nov. 19 at 10:35 AM
$NKGN I believe there is one day we all be super happy cus of this stock.
0 · Reply
BCINU
BCINU Nov. 17 at 4:54 PM
$NKGN do some research it’s not filing bankruptcy
0 · Reply
Picklerinthekitchen
Picklerinthekitchen Nov. 16 at 7:21 PM
$NKGN if you can’t buy this company’s stock how does it go up ?!
0 · Reply
Picklerinthekitchen
Picklerinthekitchen Nov. 14 at 10:58 PM
$NKGN has this. Company filed for bankruptcy yet ?
1 · Reply
RupertDCat
RupertDCat Nov. 14 at 3:59 PM
$NKGN Paul Song posted this today on his Linked In page. Great to spend the day planning the launch of troculeucel in Japan with Rob Claar and the HekaBio K.K. team. The Japanese Society for Regenerative Medicine (JSRM), recently announced the adoption of the “YOKOHAMA Declaration 2025” establishing clear guidelines for the use of cell therapy products like ours. As a result we can begin to offer our autologous non-genetically modified NK cell therapy on a commercial basis in Japan (where numerous autologous cell therapies are already readily available legally), while we work towards full U.S. FDA and Japan PMDA approval for neurodegenerative diseases.
1 · Reply
jiggs10
jiggs10 Nov. 14 at 2:28 PM
$NKGN. I really don't believe this thing survives. N you can't buy it n I wouldn't recommend even if u could
1 · Reply
RupertDCat
RupertDCat Nov. 12 at 12:36 AM
$NKGN worth listening to https://youtu.be/Df2eRirXn1E
0 · Reply
RupertDCat
RupertDCat Nov. 12 at 12:33 AM
$NKGN Paul Song Linked In page one week ago. In February we started to treat this lovely woman with a C9orf72 mutation who had the behavioral variant of frontotemporal dementia (bvFTD) under a single compassionate use IND. This once loving wife-mother-grandmother had become very apathetic and emotionally withdrawn especially around her loved ones. After several treatments with troculeucel, she started to show real positive improvements in her mood and now after 11 treatments her husband reports that "she has been more engaging with family and friends and exhibits stable normal behavior on most days". In addition in comparison to a pre-treatment PET scan performed 20 months ago, her latest PET scan shows "Overall stable to improvement in metabolic appearance. In a disease for which there is no proven therapy, this is extremely unprecedented and very encouraging and we look forward to expanding our work with the team at UCLA led by Dr. Mario Mendez and Jessica Rexach.
1 · Reply
Latest News on NKGN
No data available.
prismmarketview
prismmarketview Nov. 25 at 5:13 PM
PRISM Mid-Day Movers: Global Health and NextGen tech & AI Lead Todays Charge. NKGen Biotech (NASDAQ: $NKGN) jumped about 48% to $0.031, driven by speculative interest and volatility, while Symbotic (NASDAQ: $SYM) surged 34% to $74.52 after beating Q4 revenue estimates with $618.5M and strong growth signals, reflecting bullish momentum. Other Notable Movers: Amentum ( $AMTM) up 20% Roadzen ( $RDZN) up 11% GreenPower Motor Company Inc. ( $GP.X) https://prismmarketview.com/prism-mid-day-movers-global-health-and-nextgen-tech-ai-lead-todays-charge/
0 · Reply
Picklerinthekitchen
Picklerinthekitchen Nov. 25 at 2:32 AM
$NKGN finally .03 !
0 · Reply
Abdullah5566
Abdullah5566 Nov. 19 at 10:35 AM
$NKGN I believe there is one day we all be super happy cus of this stock.
0 · Reply
BCINU
BCINU Nov. 17 at 4:54 PM
$NKGN do some research it’s not filing bankruptcy
0 · Reply
Picklerinthekitchen
Picklerinthekitchen Nov. 16 at 7:21 PM
$NKGN if you can’t buy this company’s stock how does it go up ?!
0 · Reply
Picklerinthekitchen
Picklerinthekitchen Nov. 14 at 10:58 PM
$NKGN has this. Company filed for bankruptcy yet ?
1 · Reply
RupertDCat
RupertDCat Nov. 14 at 3:59 PM
$NKGN Paul Song posted this today on his Linked In page. Great to spend the day planning the launch of troculeucel in Japan with Rob Claar and the HekaBio K.K. team. The Japanese Society for Regenerative Medicine (JSRM), recently announced the adoption of the “YOKOHAMA Declaration 2025” establishing clear guidelines for the use of cell therapy products like ours. As a result we can begin to offer our autologous non-genetically modified NK cell therapy on a commercial basis in Japan (where numerous autologous cell therapies are already readily available legally), while we work towards full U.S. FDA and Japan PMDA approval for neurodegenerative diseases.
1 · Reply
jiggs10
jiggs10 Nov. 14 at 2:28 PM
$NKGN. I really don't believe this thing survives. N you can't buy it n I wouldn't recommend even if u could
1 · Reply
RupertDCat
RupertDCat Nov. 12 at 12:36 AM
$NKGN worth listening to https://youtu.be/Df2eRirXn1E
0 · Reply
RupertDCat
RupertDCat Nov. 12 at 12:33 AM
$NKGN Paul Song Linked In page one week ago. In February we started to treat this lovely woman with a C9orf72 mutation who had the behavioral variant of frontotemporal dementia (bvFTD) under a single compassionate use IND. This once loving wife-mother-grandmother had become very apathetic and emotionally withdrawn especially around her loved ones. After several treatments with troculeucel, she started to show real positive improvements in her mood and now after 11 treatments her husband reports that "she has been more engaging with family and friends and exhibits stable normal behavior on most days". In addition in comparison to a pre-treatment PET scan performed 20 months ago, her latest PET scan shows "Overall stable to improvement in metabolic appearance. In a disease for which there is no proven therapy, this is extremely unprecedented and very encouraging and we look forward to expanding our work with the team at UCLA led by Dr. Mario Mendez and Jessica Rexach.
1 · Reply
BCINU
BCINU Nov. 11 at 4:13 PM
$NKGN small cap biotechs coming back to life. This company has a future.
1 · Reply
Picklerinthekitchen
Picklerinthekitchen Nov. 6 at 4:46 PM
$NKGN
0 · Reply
BCINU
BCINU Nov. 3 at 12:47 PM
$NKGN be patient still a great investment with a future
2 · Reply
Abdullah5566
Abdullah5566 Nov. 2 at 4:09 AM
$NKGN Any news regarding back to OTC !
2 · Reply
Dadisong
Dadisong Oct. 31 at 3:28 PM
$NKGN Q pena de stock!
0 · Reply
Picklerinthekitchen
Picklerinthekitchen Oct. 25 at 3:36 AM
$NKGN
0 · Reply
Picklerinthekitchen
Picklerinthekitchen Oct. 16 at 1:22 AM
$NKGN one day !
0 · Reply
prismmarketview
prismmarketview Oct. 13 at 5:23 PM
PRISM MarketVier Mid-Day Movers: Global Health and Pharmaceuticals lead tosays movement. NKGen Biotech surges +567%, $NKGN Quoin Pharmaceuticals jumps +151%, $QNRX leading gains in global health & pharma sectors today. Texas Mineral $TMRC (+30%) and Super League $SLE (+18%) also strong. https://prismmarketview.com/prism-marketview-mid-day-movers-global-health-and-pharmaceuticals-lead-tosays-movement/
0 · Reply
RupertDCat
RupertDCat Oct. 9 at 5:30 PM
$NKGN https://www.tipranks.com/news/the-fly/nkgen-biotech-provides-clarification-on-quotation-display-trading-status-thefly
0 · Reply
BCINU
BCINU Oct. 9 at 2:20 PM
$NKGN on my level III trading platform I am showing it has a bid price of 20 cents and sell price of 40 cents. Thats the common investor but we are unable to buy. If we sell at market it will go for a penny because the market makers is buying.
1 · Reply
BCINU
BCINU Oct. 9 at 2:17 PM
$NKGN my understanding is the common investor cannot buy through big broker only the market makers can buy. Do not panic sell! This company is not going under. It does have future. Need to wait for it to reapply to Nasdaq and it will. Just hope it is next 6 months.
2 · Reply
jskstocks
jskstocks Oct. 9 at 12:24 PM
$NKGN I get that this is moving to the pink sheets and may be temporarily hard to trade with some brokerages, but to dip to fractions of a penny seems way out of whack. Also, the move to pink sheets should be quite fast. Not sure what is really going on.
0 · Reply